{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:34:29Z","timestamp":1790786069805,"version":"4.1.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Corticosteroids are a common option used in sepsis treatment. However, the efficacy and potential risk of corticosteroids in septic patients have not been well assessed. This review was performed to assess the efficacy and safety of corticosteroids in patients with sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PubMed, Embase, and Cochrane library databases were searched from inception to March 2021. Randomized controlled trials (RCTs) that evaluated the effect of corticosteroids on patients with sepsis were included. The quality of outcomes in the included articles was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation methodology. The data were pooled by using risk ratio (RR) and mean difference (MD). The random-effects model was used to evaluate the pooled MD or RR and 95% confidence intervals (CIs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty RCTs that included 12,304 patients with sepsis were identified. Corticosteroids were not associated with the mortality in 28-day (RR, 0.94; 95% CI, 0.87\u20131.02; evidence rank, moderate) and long-term mortality (&amp;gt;60 days) (RR, 0.96; 95% CI, 0.88\u20131.05) in patients with sepsis (evidence rank, low). However, corticosteroids may exert a significant effect on the mortality in the intensive care unit (ICU) (RR, 0.9; 95% CI, 0.83\u20130.97), in-hospital (RR, 0.9; 95% CI, 0.82\u20130.99; evidence rank, moderate) in patients with sepsis or septic shock (evidence rank, low). Furthermore, corticosteroids probably achieved a tiny reduction in the length of hospital stay and ICU. Corticosteroids were associated with a higher risk of hypernatremia and hyperglycemia; furthermore, they appear to have no significant effect on superinfection and gastroduodenal bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Corticosteroids had no significant effect on the 28-day and long-term mortality; however, they decreased the ICU and hospital mortality. The findings suggest that the clinical corticosteroids may be an effective therapy for patients with sepsis during the short time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:uri>https:\/\/inplasy.com\/wp-content\/uploads\/2021\/05\/INPLASY-Protocol-1074-4.pdf<\/jats:uri><\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.709155","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T10:43:10Z","timestamp":1629110590000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Corticosteroids for Treating Sepsis in Adult Patients: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Huoyan","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quancheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004842","article-title":"Sepsis Subclasses: A Framework for Development and Interpretation","volume":"49","author":"DeMerle","year":"2021","journal-title":"Crit Care Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4914-x","article-title":"Critical Illness-Related Corticosteroid Insufficiency (CIRCI): A Narrative Review From a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"Cd002243","DOI":"10.1002\/14651858.CD002243.pub4","article-title":"Corticosteroids for Treating Sepsis in Children and Adults","volume":"12","author":"Annane","year":"2019","journal-title":"Cochrane Database Systematic Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22176","article-title":"Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial","volume":"323","author":"Fujii","year":"2020","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.24505","article-title":"Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial","volume":"325","author":"Sevransky","year":"2021","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cQuality of Evidence\u201d and Why is it Important to Clinicians","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical Res ed)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B14","article-title":"Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [Updated March 2011]","author":"Higgins","year":"2011","journal-title":"Cochrane Collaboration"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical Res ed)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s Tool for Assessing Risk of Bias in Randomised Trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clinical Res ed)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcdt.2013.02.013","article-title":"Effects of Methyl Prednisolone in Early ARDS","volume":"62","author":"Abdelsalam Rezk","year":"2013","journal-title":"Egyptian J Chest Dis Tuberculosis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31816f48f2","article-title":"Hydrocortisone Effects on Cardiovascular Variability in Septic Shock: A Spectral Analysis Approach","volume":"36","author":"Aboab","year":"2008","journal-title":"Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults: A Randomized Controlled Trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone Plus Fludrocortisone for Adults With Septic Shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090707","article-title":"Low-Dose Hydrocortisone in Patients With Cirrhosis and Septic Shock: A Randomized Controlled Trial","volume":"182","author":"Arabi","year":"2011","journal-title":"CMAJ: Can Med Assoc J = J l\u2019Association medicale Can"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct Prednisone Therapy for Patients With Community-Acquired Pneumonia: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet (Lond Engl)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of Late Septic Shock With Supraphysiologic Doses of Hydrocortisone","volume":"26","author":"Bollaert","year":"1998","journal-title":"Crit Care Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198709103171101","article-title":"A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress Doses of Hydrocortisone Reverse Hyperdynamic Septic Shock: A Prospective, Randomized, Double-Blind, Single-Center Study","volume":"27","author":"Briegel","year":"1999","journal-title":"Crit Care Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"33A","DOI":"10.1097\/00003246-199901001-00022","article-title":"Hydrocortisone Reverses Refractory Septic Shock","volume":"27","author":"Chawla","year":"1999","journal-title":"Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-31802006000200008","article-title":"Effects of Single Dose of Dexamethasone on Patients With Systemic Inflammatory Response","volume":"124","author":"Cicarelli","year":"2007","journal-title":"Sao Paulo Med J = Rev paulista medicina"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone Infusion for Severe Community-Acquired Pneumonia: A Preliminary Randomized Study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2002808","DOI":"10.1183\/13993003.02808-2020","article-title":"Intravenous Methylprednisolone Pulse as a Treatment for Hospitalised Severe COVID-19 Patients: Results From a Randomised Controlled Clinical Trial","volume":"56","author":"Edalatifard","year":"2020","journal-title":"Eur Respir J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/cc10103","article-title":"Effect of Corticosteroids on the Clinical Course of Community-Acquired Pneumonia: A Randomized Controlled Trial","volume":"15","author":"Fern\u00e1ndez-Serrano","year":"2011","journal-title":"Crit Care (Lond Engl)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000212","article-title":"The Interaction of Vasopressin and Corticosteroids in Septic Shock: A Pilot Randomized Controlled Trial","volume":"42","author":"Gordon","year":"2014","journal-title":"Crit Care Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198709103171102","article-title":"Effect of High-Dose Glucocorticoid Therapy on Mortality in Patients With Clinical Signs of Systemic Sepsis","volume":"317","year":"1987","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1003-0603.2009.09.006","article-title":"[The Effect of Low-Dose Hydrocortisone on Requirement of Norepinephrine and Lactate Clearance in Patients With Refractory Septic Shock]","volume":"21","author":"Hu","year":"2009","journal-title":"Zhongguo wei zhong bing ji jiu yi xue = Chin Crit Care Med = Zhongguo weizhongbing jijiuyixue"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.2095-4352.2014.03.012","article-title":"[Effect of Sini Decoction on Function of Hypothalamic-Pituitary-Adrenal Axis in Patients With Sepsis]","volume":"26","author":"Huang","year":"2014","journal-title":"Zhonghua wei zhong bing ji jiu yi xue"},{"key":"B39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/SHK.0000000000000665","article-title":"Effects of Increasing Hydrocortisone to 300\u200aMg Per Day in the Treatment of Septic Shock: A Pilot Study","volume":"46","author":"Hyvernat","year":"2016","journal-title":"Shock (Augusta Ga)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200205-446OC","article-title":"Immunologic and Hemodynamic Effects of \u201cLow-Dose\u201d Hydrocortisone in Septic Shock: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study","volume":"167","author":"Keh","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197106032842206","article-title":"Effectiveness of Betamethasone in Management of Severe Infections. A Double-Blind Study","volume":"284","author":"Klastersky","year":"1971","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1186\/cc5696","article-title":"Effect of Mode of Hydrocortisone Administration on Glycemic Control in Patients With Septic Shock: A Prospective Randomized Trial","volume":"11","author":"Loisa","year":"2007","journal-title":"Crit Care (Lond Engl)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.1.62","article-title":"Ineffectiveness of High-Dose Methylprednisolone in Preventing Parenchymal Lung Injury and Improving Mortality in Patients With Septic Shock","volume":"138","author":"Luce","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.06.004","article-title":"Early Initiation of Low-Dose Hydrocortisone Treatment for Septic Shock in Adults: A Randomized Clinical Trial","volume":"35","author":"Lv","year":"2017","journal-title":"Am J Emergency Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone Infusion in Early Severe ARDS: Results of a Randomized Controlled Trial","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"45S","DOI":"10.1016\/S0012-3692(16)48001-3","article-title":"Prospective Double-Blind Randomized Clinical Trial on the Effects of Low-Dose Hydrocortisone Infusion in Patients With Severe Sepsis","volume":"136","author":"Meduri","year":"2009","journal-title":"Chest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and Length of Hospital Stay in Patients With Community-Acquired Pneumonia: A Randomised, Double-Blind, Placebo-Controlled Trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet (Lond Engl)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"P239","DOI":"10.1186\/cc13429","article-title":"Continuous Administration of Corticosteroids in Septic Shock can Reduce Risk of Hypernatremia","volume":"18","author":"Mirea","year":"2014","journal-title":"Crit Care"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcdt.2013.03.009","article-title":"Adjuvant Role of Corticosteroids in the Treatment of Community-Acquired Pneumonia","volume":"62","author":"Nafae","year":"2013","journal-title":"Egyptian J Chest Dis Tuberculosis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000186370.78639.23","article-title":"Low-Dose Hydrocortisone Improves Shock Reversal and Reduces Cytokine Levels in Early Hyperdynamic Septic Shock","volume":"33","author":"Oppert","year":"2005","journal-title":"Crit Care Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000233872.04706.BB","article-title":"Low-Dose Hydrocortisone During Severe Sepsis: Effects on Microalbuminuria","volume":"34","author":"Rinaldi","year":"2006","journal-title":"Crit Care Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4236\/pp.2011.22009","article-title":"Corticosteroids and ICU Course of Community Acquired Pneumonia in Egyptian Settings","volume":"2","author":"Sabry","year":"2011","journal-title":"Pharmacol Pharm"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the Treatment of Clinical Septic Shock","volume":"184","author":"Schumer","year":"1976","journal-title":"Ann Surg"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of Corticosteroids in Community-Acquired Pneumonia: A Randomized Double-Blinded Clinical Trial","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone Therapy for Patients With Septic Shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411013111801","article-title":"The Effects of High-Dose Corticosteroids in Patients With Septic Shock. A Prospective, Controlled Study","volume":"311","author":"Sprung","year":"1984","journal-title":"N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15171\/jept.2017.25","article-title":"The Effect of Physiologic Dose of Intravenous Hydrocortisone in Patients With Refractory Septic Shock: A Randomized Control Trial","volume":"4","author":"Talebi Doluee","year":"2018","journal-title":"J Emergency Pract Trauma"},{"key":"B59","first-page":"A24","article-title":"Corticosteroids","author":"Tandan","year":"2005","journal-title":"Proc Am Thoracic Soc Meeting"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001316","article-title":"Comparison Between Continuous and Intermittent Administration of Hydrocortisone During Septic Shock: A Randomized Controlled Clinical Trial","volume":"52","author":"Tilouche","year":"2019","journal-title":"Shock (Augusta Ga)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone Treatment in Early Sepsis-Associated Acute Respiratory Distress Syndrome: Results of a Randomized Controlled Trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Crit Care (Lond Engl)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.88","article-title":"Effect of Corticosteroids on Treatment Failure Among Hospitalized Patients With Severe Community-Acquired Pneumonia and High Inflammatory Response: A Randomized Clinical Trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"B64","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive Glucocorticoid Therapy in Patients With Septic Shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1186\/cc1498","article-title":"Physiological-Dose Steroid Therapy in Sepsis [ISRCTN36253388]","volume":"6","author":"Yildiz","year":"2002","journal-title":"Crit Care (Lond Engl)"},{"key":"B66","article-title":"The Effects of Moderate-Dose Steroid Therapy in Sepsis: A Placebo-Controlled, Randomized Study","volume":"16","author":"Yildiz","year":"2011","journal-title":"J Res Med Sciences: Off J Isfahan Univ Med Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-1733","article-title":"Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis","volume":"149","author":"Wan","year":"2016","journal-title":"Chest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.815","article-title":"Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review","volume":"301","author":"Annane","year":"2009","journal-title":"JAMA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"Cd002243","DOI":"10.1002\/14651858.CD002243.pub3","article-title":"Corticosteroids for Treating Sepsis","volume":"2015","author":"Annane","year":"2015","journal-title":"Cochrane Database Systematic Rev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3899-6","article-title":"Glucocorticosteroids for Sepsis: Systematic Review With Meta-Analysis and Trial Sequential Analysis","volume":"41","author":"Volbeda","year":"2015","journal-title":"Intensive Care Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of Corticosteroid Treatment With Outcomes in Adult Patients With Sepsis: A Systematic Review and Meta-Analysis","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Internal Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5492\/wjccm.v6.i1.65","article-title":"Timing, Method and Discontinuation of Hydrocortisone Administration for Septic Shock Patients","volume":"6","author":"Ibarra-Estrada","year":"2017","journal-title":"World J Crit Care Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000072","article-title":"Fludrocortisone and Hydrocortisone, Alone or in Combination, on In Vivo Hemodynamics and In Vitro Vascular Reactivity in Normal and Endotoxemic Rats: A Randomized Factorial Design Study","volume":"63","author":"Laviolle","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-4179(03)00148-7","article-title":"Hydrocortisone Improved Haemodynamics and Fluid Requirement in Surviving But Not Non-Surviving of Severely Burned Patients","volume":"29","author":"Winter","year":"2003","journal-title":"Burns: J Int Soc Burn Injuries"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001651","article-title":"Evaluation of the Initiation Timing of Hydrocortisone in Adult Patients With Septic Shock","volume":"55","author":"Sacha","year":"2021","journal-title":"Shock (Augusta Ga)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.6.9812004","article-title":"Effects of Nitric Oxide in Septic Shock","volume":"161","author":"Vincent","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"B77","article-title":"Pathophysiology of Cardiovascular Dysfunction in Septic Shock","volume":"6","author":"Parker","year":"1998","journal-title":"New Horizons (Baltimore Md)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199301000-00010","article-title":"Impaired Beta-Adrenergic Receptor Stimulation of Cyclic Adenosine Monophosphate in Human Septic Shock: Association With Myocardial Hyporesponsiveness to Catecholamines","volume":"21","author":"Silverman","year":"1993","journal-title":"Crit Care Med"},{"key":"B79","article-title":"Hepatic Alpha 1-Adrenergic Receptor Alteration in a Rat Model of Chronic Sepsis","volume":"19","author":"McMillan","year":"1986","journal-title":"Circulatory Shock"},{"key":"B80","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/cs0820597","article-title":"Corticosteroids and Vascular Tone: Mapping the Messenger Maze","volume":"82","author":"Walker","year":"1992","journal-title":"Clin Sci (London England: 1979)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199206000-00025","article-title":"Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"}],"updated-by":[{"DOI":"10.3389\/fimmu.2021.771779","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.709155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T15:20:15Z","timestamp":1636125615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.709155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2021.709155"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.709155","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2021.771779","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"article-number":"709155"}}